StreetAlpha.app
Home › Stocks › IQV

Iqvia Holdings Inc. (IQV)

Healthcare
$257.59
▼ −2.69%
LAST CLOSE · NOV 17

IQVIA provides clinical research, commercial insights and healthcare data services to life sciences and healthcare companies. It last closed at $257.59 on Nov 17, down 2.69% on the day. IQV reports earnings on Thu, Feb 4, 2027. The average 12-month price target from 11 analysts is $313.91 (+21.9% from the last close), with a high of $346.00 and a low of $270.00. Analyst consensus is Strong Buy, based on the latest ratings from 11 firms (10 buy, 1 hold, 0 sell). Over the past 90 days StreetAlpha recorded 8 whale options trades in IQV, 75% of them bullish and 25% bearish. In the past 30 days there were 7 dark pool prints totaling $10.0M, the largest $3.8M.

AI Auto Pilots
Is IQV in one of our four AI portfolios? Sign in free to see

Key Stats

Last 12 months
Results
Revenue
$17.3B
+8.8% vs a year ago
Net income
$1.4B
+8.7% vs a year ago
EPS (diluted)
$8.22
+13.1% vs a year ago
Free cash flow
$2.1B
12.0% margin
Valuation
Market cap
$42.5B
164.8M shares
P/E
31.3
Price over 12 month EPS
Price to sales
2.5
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$2.2B
At Sep 30
Debt
$16.1B
At Sep 30
Shareholder equity
$6.7B
Buybacks
$1.2B
Last 12 months
Employees95,000 (Sep 30, 2026)
Fiscal year endsDecember
ExchangeNYSE
Financials history
FY2021: $13.9B$13.9BFY2021FY2022: $14.4B$14.4BFY2022FY2023: $15.0B$15.0BFY2023FY2024: $15.4B$15.4BFY2024FY2025: $16.3B$16.3BFY2025

From IQV's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Oct 27). Last 12 months adds up the four latest quarters.

Next report
Feb 4
2027 · Time not announced
Consensus EPS forecast
$3.60
$4.53B revenue est.
Year-ago EPS
—
Not on file
Options-implied move
—
Posted about a week before
Analyst consensus
Strong Buy
Based on 11 analyst ratings (90 days)
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Consensus · 90 days
Strong Buy
11firms
10 Buy1 Hold0 Sell
Each firm's latest rating on IQV in the past 90 days
Average 12-month target
$313.91
▲ 21.9% upside

Based on 11 analysts who set a price target on IQV in the past 90 days. The average target is $313.91, with a high of $346.00 and a low of $270.00, compared with the last close of $257.59.

Low $270.00Avg $313.91High $346.00
Blue marker: last close $257.59
Highest target$346.00
Average target$313.91
Lowest target$270.00
Latest rating changes
TD CowenTarget raised
Oct 29Buy$288 → $307
JP MorganTarget raised
Oct 28Buy$285 → $325
Truist SecuritiesTarget raised
Oct 28Buy$329 → $346
Evercore ISI GroupMaintained
Oct 28Buy$310
BairdTarget raised
Oct 28Buy$287 → $328
DateFirmActionRatingPrice target
Oct 29TD CowenTarget raisedBuy$288 → $307
Oct 28JP MorganTarget raisedBuy$285 → $325
Oct 28Truist SecuritiesTarget raisedBuy$329 → $346
Oct 28Evercore ISI GroupMaintainedBuy$310
Oct 28BairdTarget raisedBuy$287 → $328
Loading…

Technical Analysis

IQV · as of the Nov 17 close · updated after every close
Pullback inside a longer uptrend

The stock is 5% below its 20 day and 4% below its 50 day average. It is 18% above its 200 day average, so the longer trend is still up. Momentum is weak (RSI 40). The nearest support is the Pivot S1 at $255.30, and the nearest resistance the Pivot at $259.69.

Short trendBearish
Long trendBullish
MomentumWeak
StretchNormal
VolatilityNormal, 3.3%/day
Key levels
$284.5052 week high+10.4%
$270.4620 day average+5.0%
$267.3150 day average+3.8%
$265.25Swing high (Aug 27)+3.0%
$261.98Pivot R1+1.7%
$259.69Pivot+0.8%
$257.59Last close
$255.30Pivot S1−0.9%
$253.63Swing low (Nov 3)−1.5%
$249.40100 day average−3.2%
$211.33200 day average−18.0%
$154.5052 week low−40.0%
Indicators
RSI (14)40.36Middle of its rangeNeutral
MACD-0.29Below its signal lineBearish
Stochastic29.9Middle of its rangeNeutral
ADX (14)17.3No clear trend
Williams %R-85.7Oversold below −80, overbought above −20Oversold
CCI (20)-129.8Oversold below −100, overbought above 100Oversold
Rate of change−1.9%Change over 10 sessionsBearish
ATR (14)$8.60Typical daily range, 3.3% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Above
MA 200Above
What happened before, for IQV

What happened before

See how IQV did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

Whale flow leans bullish6 bullish and 2 bearish whale options trades in the last 90 days. See Whale Flow
November seasonalityHow IQV usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Seasonality

How IQV has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2013.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Total alerts
8
Bullish
6
75%
Bearish
2
25%
Date span
Sep 17 – Nov 10
Loading…

See today’s whale options flow across the market →

Dark Pool

30D
Prints
7
Notional
$10.0M
Largest print
$3.8M
Loading…

IQV Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Neutral
Strongly bearishNeutralStrongly bullish
  • ▲614 buying vs 521 selling
  • ▼Held by funds -2.8 pts
  • ▲Funds holding +125
  • ▲Superinvestors: 4 added, 0 cut
  • ▼Put/call 0.34 to 3.39
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding1,2171,092+11.4%
In funds' top 102412+100.0%
Held by funds92.9%95.7%−2.8 pts
New / increased217 / 397125 / 396+17.9%
Reduced / sold out443 / 78428 / 111−3.3%
Put/call ratio3.390.34+887.2%
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See IQV institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

IQV Stock Buybacks

See all S&P 500 buybacks →
Spent, 12 months
$1.2B
2.7% yield
Left in program
$2.8B
6.6% of value
Shares outstanding, 12 months
−3.2%
Fewer shares
Last quarter
$0
Sep 2026
Avg price paid, last quarter
—
 
S&P 500 rank by spending
#164 of 358
 
Spent each quarter, last 3 yearsTop bar $1.1B
Dec 2023: $234.1M, average price $195.06Mar 2024: $0Jun 2024: $0Sep 2024: $195.0M, average price $243.77Dec 2024: $1.1B, average price $204.83Mar 2025: $420.8M, average price $182.95Jun 2025: $613.9M, average price $149.74Sep 2025: $0Dec 2025: $216.5M, average price $216.48Mar 2026: $549.1M, average price $171.60Jun 2026: $395.2M, average price $171.81Sep 2026: $0
Dec 2023Sep 2026
For membersMonth by month buying, shares and the average price paid each month are shown to AI Starter and AI Pro members.

From the company's 10-Q filed Oct 27, 2026. Quarters are the company's own fiscal quarters. Yield and % of value use the latest close. Buybacks are not a forecast: in our testing, the biggest buyers did about the same as the average S&P 500 stock.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether IQV is in one of them and how their past IQV trades turned out.

IQV in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered IQV in an article yet. Here's the latest on the wider market.

IQV Congress Trades

All congress trades →
Trades, 12 months
16
Buys
3
19%
Sells
13
81%
People
4
Last filed Sep 28
Who traded IQV · since 2019
Latest 5 filings of 84
$15K – $50KTraded Sep 14, 2026Filed Sep 28, 2026
$1K – $15KTraded Sep 8, 2026Filed Sep 28, 2026
$1K – $15KTraded Sep 8, 2026Filed Sep 28, 2026
$1K – $15KTraded Sep 3, 2026Filed Sep 28, 2026
$1K – $15KTraded Sep 3, 2026Filed Sep 28, 2026
PersonTypeAmountTradedFiledDelay
Kevin HernR · OKSell$15K – $50KSep 14, 2026Sep 28, 202614 d
Kevin HernR · OKSell$1K – $15KSep 8, 2026Sep 28, 202620 d
Kevin HernR · OKSell$1K – $15KSep 8, 2026Sep 28, 202620 d
Kevin HernR · OKSell$1K – $15KSep 3, 2026Sep 28, 202625 d
Kevin HernR · OKSell$1K – $15KSep 3, 2026Sep 28, 202625 d

Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.

About Iqvia Holdings

IQVIA provides clinical research services, commercial insights and healthcare data analytics. Its offerings cover clinical trial design and patient recruitment, sales and marketing operations, and real world evidence built from a large set of healthcare information, including prescription, medical claims and electronic medical record data. Its customers include pharmaceutical, biotech and medical device companies, medical researchers, government agencies and payers. The company is headquartered in Durham, North Carolina.

Headquarters
Durham, NC
Founded
2016